Disease-modifying therapies should be stopped in NMOSD patients in remission – Yes
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- August 2019
has subject area
- 1103 Clinical Sciences (FoR)
- 1109 Neurosciences (FoR)
- Adult (MeSH)
- Disease Progression (MeSH)
- Humans (MeSH)
- Immunologic Factors (MeSH)
- Neurology & Neurosurgery (Science Metrix)
- Neuromyelitis Optica (MeSH)
published in
- Multiple Sclerosis Journal